# ARC/Manchester, NH – FDA 483, Apr 29, 2026

Source: https://www.keypedia.com/records/483/arcmanchester-nh/67b85783-aac1-458f-9dfd-c4278cb77012

> FDA 483 for ARC/Manchester, NH on April 29, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ARC/Manchester, NH
- Inspection Date: 2026-04-29
- Product Type: biologics
- Office Name: New England District Office
- Summary: An FDA inspection of the American Red Cross Manchester Fixed Site, a blood donor center, revealed a significant concern regarding the preparation of phlebotomy sites. Investigators observed phlebotomists using non-sterile markers and improper arm preparation methods, which compromises the assurance of a sterile container of Whole Blood. This practice indicates a potential risk to product sterility and donor safety.

## Related Officers

- [Kenneth L. Smalls](https://www.keypedia.com/people/kenneth-l-smalls/7625258c-cada-4506-8daa-a64374cf9f15)

Company: https://www.keypedia.com/companies/arcmanchester-nh/9cbc9f7b-0cca-4a46-b934-a9d259f1b06b

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144